drugset / Trial / NCT02999022

Lithium for Fracture Treatment: a Double Blind Randomized Controlled Trial (LiFT)

NCT02999022

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a study designed to see if a low dose of Lithium treatment, taken for 2 weeks, can improve fracture healing and improve patients' function and productivity.

Timeline

Start
2017-07-21
Primary completion
2024-12
Completion
2025-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Lithium Carbonate Unknown 300 mg

Indications

No indication recorded.